Outcome Trends After Hip Arthroscopy for Femoroacetabular Impingement: When Do Patients Improve?

医学 髋关节镜检查 最小临床重要差异 股骨髋臼撞击 外科 关节镜检查 置信区间 体质指数 随机对照试验 内科学
作者
Theodore Wolfson,Michael K. Ryan,John P. Begly,Thomas Youm
出处
期刊:Arthroscopy [Elsevier]
卷期号:35 (12): 3261-3270 被引量:51
标识
DOI:10.1016/j.arthro.2019.06.020
摘要

To determine when patients reach critical thresholds of clinical improvement after hip arthroscopy for femoroacetabular impingement (FAI) using previously defined cutoffs for the minimal clinically important difference (MCID) and patient acceptable symptomatic state (PASS) and to identify risk factors for prolonged recovery.Consecutive patients with a diagnosis of FAI who underwent unilateral hip arthroscopy between January 2010 and January 2015 with at least 2 years of clinical follow-up were studied. The modified Harris Hip Score was collected prospectively at 6 consecutive time points. The number of patients reaching the MCID and PASS at each time point was determined.During the study period, 340 consecutive hip arthroscopies were performed in 316 patients with a mean final follow-up period of 50 months (range, 29-84 months). The mean modified Harris Hip Score and percentage of patients reaching the MCID and PASS increased at each time point. At 2 years, 271 patients (93%) surpassed the MCID and 212 patients (73%) achieved the PASS. Female sex, age of 40 years or older, and body mass index of 30 or greater were associated with lower rates of achieving the MCID and PASS at set time points. Patients undergoing labral repair had superior PASS rates at 3 months and beyond than patients undergoing labral debridement alone. Patients who did not achieve the PASS by 3 months were more likely to require reoperation.Hip arthroscopy for FAI results in increased patient-reported outcome measures at interval follow-up. Most patients reach critical thresholds of minimal and satisfactory clinical improvement. Patients who are female, older, or obese or who undergo labral debridement alone are less likely to reach these milestones at major time intervals. Patients who do not reach the PASS by 3 months are more likely to require reoperation.Level IV, therapeutic case series.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
超爱蛋炒饭完成签到,获得积分10
1秒前
zb发布了新的文献求助10
1秒前
1秒前
儒雅不弱完成签到,获得积分20
1秒前
付佳佳完成签到,获得积分10
2秒前
zyl完成签到,获得积分10
2秒前
3秒前
飘逸宫苴发布了新的文献求助10
4秒前
闲云野鹤完成签到,获得积分10
4秒前
4秒前
大个应助科研小菜采纳,获得10
7秒前
8秒前
丁老三完成签到,获得积分10
8秒前
JXDYYZK完成签到,获得积分10
8秒前
加加油完成签到,获得积分10
9秒前
df发布了新的文献求助10
9秒前
W6完成签到,获得积分10
9秒前
一天三个蛋完成签到 ,获得积分10
10秒前
万能图书馆应助迅速文龙采纳,获得10
11秒前
Orange应助τ涛采纳,获得10
11秒前
小星星完成签到 ,获得积分10
11秒前
笑羽完成签到,获得积分10
12秒前
科研通AI2S应助万松辉采纳,获得10
13秒前
zh发布了新的文献求助10
13秒前
wanci应助莫言采纳,获得10
13秒前
14秒前
acaizr发布了新的文献求助200
16秒前
小张完成签到,获得积分10
16秒前
bkagyin应助qq采纳,获得10
17秒前
17秒前
llyric完成签到,获得积分10
17秒前
ATYS完成签到,获得积分10
18秒前
11111完成签到 ,获得积分10
19秒前
充电宝应助激昂的白凡采纳,获得10
19秒前
俭朴钢铁侠完成签到 ,获得积分10
19秒前
Lrh完成签到 ,获得积分10
19秒前
20秒前
小鱼完成签到 ,获得积分10
21秒前
传奇3应助杰森斯坦虎采纳,获得10
21秒前
21秒前
高分求助中
Contemporary Issues in Evaluating Treatment Outcomes in Neurodevelopmental Disorders 1000
rhetoric, logic and argumentation: a guide to student writers 1000
QMS18Ed2 | process management. 2nd ed 1000
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
A Chronicle of Small Beer: The Memoirs of Nan Green 1000
From Rural China to the Ivy League: Reminiscences of Transformations in Modern Chinese History 900
Eric Dunning and the Sociology of Sport 850
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 免疫学 细胞生物学 电极
热门帖子
关注 科研通微信公众号,转发送积分 2916167
求助须知:如何正确求助?哪些是违规求助? 2556367
关于积分的说明 6913976
捐赠科研通 2216677
什么是DOI,文献DOI怎么找? 1178181
版权声明 588403
科研通“疑难数据库(出版商)”最低求助积分说明 576664